Titan Pharmaceuticals Inc (TTNP): Why the relatively large volume? I ca...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	41
Boards Moderated	0
Alias Born	02/18/2017

onlyimho

Re: None

Thursday, 07/13/2017 6:37:24 AM

Thursday, July 13, 2017 6:37:24 AM

Why the relatively large volume?

I can see the short sellers intending to kill a dying stock, but who is buying ... or is it all just ebb and flow of the market maker?

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TTNP News

Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM

More TTNP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover